Significant Growth Opportunities of Stem Cell Assay Market - Global Forecast to 2023
Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023 “The global stem cell assay market is expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. “ The market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments. Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=47610330 The key players in the stem cell assay market include Merck (Germany), Thermo Fisher Scientific (US), GE Healthcare (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Promega Corporation (US), Cell Biolabs (US), PerkinElmer (US), Miltenyi Biotec (Germany), HemoGenix (US), Bio-Techne Corporation (US), STEMCE...